- Home
- ZCMD vs ALGS Comparison
ZCMD vs ALGS Comparison
Compare ZCMD & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- ALGS
- Stock Information
- Founded
- ZCMD 2012
- ALGS 2018
- Country
- ZCMD China
- ALGS United States
- Employees
- ZCMD N/A
- ALGS N/A
- Industry
- ZCMD Other Consumer Services
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- ALGS Health Care
- Exchange
- ZCMD Nasdaq
- ALGS Nasdaq
- Market Cap
- ZCMD 30.3M
- ALGS 32.4M
- IPO Year
- ZCMD 2020
- ALGS 2020
- Fundamental
- Price
- ZCMD $1.13
- ALGS $4.87
- Analyst Decision
- ZCMD
- ALGS Strong Buy
- Analyst Count
- ZCMD 0
- ALGS 1
- Target Price
- ZCMD N/A
- ALGS $70.00
- AVG Volume (30 Days)
- ZCMD 6.7K
- ALGS 143.0K
- Earning Date
- ZCMD 01-01-0001
- ALGS 05-06-2025
- Dividend Yield
- ZCMD N/A
- ALGS N/A
- EPS Growth
- ZCMD N/A
- ALGS N/A
- EPS
- ZCMD N/A
- ALGS N/A
- Revenue
- ZCMD $15,864,773.00
- ALGS $3,270,000.00
- Revenue This Year
- ZCMD N/A
- ALGS $580.86
- Revenue Next Year
- ZCMD N/A
- ALGS N/A
- P/E Ratio
- ZCMD N/A
- ALGS N/A
- Revenue Growth
- ZCMD N/A
- ALGS N/A
- 52 Week Low
- ZCMD $0.95
- ALGS $3.76
- 52 Week High
- ZCMD $2.97
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- ZCMD 44.37
- ALGS 38.12
- Support Level
- ZCMD $0.95
- ALGS $4.77
- Resistance Level
- ZCMD $1.32
- ALGS $6.35
- Average True Range (ATR)
- ZCMD 0.11
- ALGS 0.65
- MACD
- ZCMD 0.00
- ALGS 0.28
- Stochastic Oscillator
- ZCMD 48.65
- ALGS 31.16
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.